Zevra Therapeutics (ZVRA) Free Cash Flow (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Free Cash Flow of $6.1 million for Q1 2026, up 10.1% on a QoQ basis from $5.5 million in Q4 2025, and up 173.39% year-over-year from $2.2 million in Q1 2025.
Zevra Therapeutics (ZVRA) Free Cash Flow (2014 - 2026) Analysis & Trends
Zevra Therapeutics' Free Cash Flow history runs 13 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- Quarterly Free Cash Flow rose 173.39% year-over-year to $6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.0 million (up 119.4% YoY) and the FY2025 annual result came in at -$2.4 million, up 96.51% from the prior year.
- Free Cash Flow was $6.1 million for Q1 2026 at Zevra Therapeutics, up from $5.5 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $6.9 million in Q1 2022 and bottomed at -$19.1 million in Q2 2024.
- A 5-year average of -$7.0 million and a median of -$6.6 million in 2022 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 367.68% in 2022, while the deepest fall reached 364.39% in 2022.
- Zevra Therapeutics' Free Cash Flow stood at -$4.0 million in 2022, then sank by 304.03% to -$16.2 million in 2023, then retreated by 0.12% to -$16.2 million in 2024, then soared by 134.14% to $5.5 million in 2025, then rose by 10.1% to $6.1 million in 2026.
- Business Quant data shows ZVRA's Free Cash Flow at $6.1 million in Q1 2026, $5.5 million in Q4 2025, and $4.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 6.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.11 Mn |
| Mar 31, 2026 | 6.11 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 4.16 Mn |
| Sep 30, 2025 | 4.16 Mn |
| Jun 30, 2025 | -3.81 Mn |
| Jun 30, 2025 | -3.81 Mn |
| Mar 31, 2025 | -8.32 Mn |
| Mar 31, 2025 | -8.32 Mn |
| Dec 31, 2024 | -16.25 Mn |
| Dec 31, 2024 | -16.25 Mn |
| Sep 30, 2024 | -18.14 Mn |
| Sep 30, 2024 | -18.14 Mn |
| Jun 30, 2024 | -19.11 Mn |
| Jun 30, 2024 | -19.11 Mn |
| Mar 31, 2024 | -16.17 Mn |
| Mar 31, 2024 | -16.17 Mn |
| Dec 31, 2023 | -16.23 Mn |
| Dec 31, 2023 | -16.23 Mn |